Quality standard for antimicrobial prophylaxis in surgical procedures

Clinical Infectious Diseases

Volumn 18, Issue 3, 1994, Pages 422-427

  Gross, Peter A ^{a,b,c,d,e,f,g,h}   Barrett, Trisha L ^{a,b,c,d,e,f,g,h}   Dellinger, E Patchen ^{a,b,c,d,e,f,g,h}   Krause, Peter J ^{a,b,c,d,e,f,g,h}   Martone, William J ^{a,b,c,d,e,f,g,h}   Mc Gowan, John E ^{a,b,c,d,e,f,g,h}   Sweet, Richard L ^{a,b,c,d,e,f,g,h}   Wenzel, Richard P ^{a,b,c,d,e,f,g,h}  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b Hackensack Medical University Cancer Center   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d Alta Bates Medical Center   (United States)

^e HARTFORD HOSPITAL   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HOSPITAL INFECTION; HUMAN; META ANALYSIS; POLICY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURGICAL TECHNIQUE; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; HUMANS; QUALITY OF HEALTH CARE; SOCIETIES, MEDICAL; SURGICAL WOUND INFECTION; UNITED STATES;

EID: 23444439669     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/18.3.422     Document Type: Article

References (49)

1. Horan TC, White JW, Jarvis WR. et al. Nosocomial infection surveillance, 1984. MMWR Morb Mortal Wkly Rep 1986;35(SS-1): 17SS-29SS.
2. Haley RW, Culver DH, White JW, Morgan WM, Emori TG. The nationwide nosocomial infection rate: a new need for vital statistics. Am J Epidemiol 1985;121:159-67.
3. Horan TC, Culver DH, Gaynes RP, Jarvis WR, Edwards JR, Reid CR. Nosocomial infections in surgical patients in the United States, January 1986-June 1992. Infect Control Hosp Epidemiol 1993; 14:73-80.
4. McGowan JE Jr. Cost and benefit of perioperative antimicrobial prophylaxis: methods for economic analysis. Rev Infect Dis 1991; 13(suppl 10):S879-89.
5. Kaiser AB, Antimicrobial prophylaxis in surgery. N Engl J Med 1986;315:1129-38.
6. Nichols RL, Postoperative infections and antimicrobial prophylaxis. In: Mandell GL, Douglas RG Jr. Bennett JE, eds. Principles and practice of infectious diseases. 2nd ed. New York: John Wiley, 1985:1637-44.
7. Polk HC Jr, Malangoni MA. Chemoprophylaxis of wound infections. In: Howard RJ, Simmons RL, eds. Surgical infectious diseases. 2nd ed. Norwalk, C’T: Appleton & Lange, 1988:351-61.
8. Meakins JL. Prophylactic antibiotics. In: Wilmore DW. Brennan MF, Harken AH, Holcroft JW, Meakins JL. eds. American College of Surgeons: care of the surgical patient. Vol 2. New York: Scientific American Medicine, 1991:1-10.
9. Anonymous. Antimicrobial prophylaxis in surgery [letter, Med Lett Drugs Ther 1992;34:5-8.
10. Page CP, Bohnen JM, Fletcher JR. McManus AT, Solomkin JS, Wittmann DH. Antimicrobial prophylaxis for surgical wounds: guidelines for clinical care. Arch Surg 1993:128:79-88.
11. ASHP Commission on Therapeutics. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Clin Pharm 1992:11:483-513.
12. Baum ML, Anish DS. Chalmers TC, Sacks HS, Smith H Jr. Fagerstrom RM. A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls. N Engl J Med 1981;305:795-9.
13. Gorbach SL. Antimicrobial prophylaxis for appendectomy and colorectal surgery. Rev Infect Dis 1991; 13(suppl 10):S815-20
14. Solla JA, Rothenberger DA. Preoperative bowel preparation: a survey of colon and rectal surgeons. Dis Colon Rectum 1990:33:154-9.
15. Ad Hoc Committee of the Committee on Trauma, Division of Medical Sciences, National Academy of Sciences-National Research Council. Postoperative wound infections: the influence of ultraviolet irradiation of the operating room and of various other factors. Ann Surg 1964; 160(suppl): 1-192.
16. Platt R, Zaleznik DF, Hopkins CC, et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med 1990;322:153-60.
17. Ergina PL, Gold S, Meakins JL. Antibiotic prophylaxis for herniorrhaphy and breast surgery [letter, N Engl J Med 1990:322:1884.
18. Rutkow IM, Robbins AW. Antibiotic prophylaxis for herniorrhaphy and breast surgery [letter, N Engl J Med 1984:322:1884.
19. Byrd DR, Brown BW, Hohn DC. Antibiotic prophylaxis for herniorrhaphy and breast surgery [letter, N Engl J Med 1990;322:1884-5.
20. Bencini PL, Galimberti M, Signorini M, Crosti C. Antibiotic prophylaxis of wound infections in skin surgery. Arch Dermatol 1991;127:1357-60.
21. Dellinger EP. Antibiotic prophylaxis of wound infections in skin surgery: is four days too much? [editorial Arch Dermatol 1991;127:1394-5.
22. Hopkins CC, Antibiotic prophylaxis in clean surgery: peripheral vascular surgery, noncardiovascular thoracic surgery, herniorrhaphy, and mastectomy. Rev Infect Dis 1991; 13(suppl 10):S869-73.
23. Platt R, Zucker JR, Zaleznik DF, et al. Prophylaxis against wound infection following herniorrhaphy or breast surgery. J Infect Dis 1992;166:556-60.
24. Platt R. Zucker JR. Zaleznik DF, et al. Perioperative antibiotic prophylaxis and wound infection following breast surgery. J Antimicrob Chemother 1993;3l(suppl B):43-8.
25. Haley RW, Culver DH, Morgan WM, White JW, Emori TG, Hooton TM. Identifying patients at high risk of surgical wound infection: a simple multivariate index of patient susceptibility and wound contaminations. Am J Epidemiol 1985;121:206-15.
26. Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med 1991;91 (suppl 3B):152S-7S.
27. Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1990;264:2919-22.
28. Classen DC, Evans RS, Pestotnik SL, Horn SD. Menlove RL. Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992;326:281-6.
29. DiPiro JT, Vallner JJ, Bowden TA Jr. Clark BA, Sisley JF. Intraoperative serum and tissue activity of cefazolin and cefoxitin. Arch Surg 1985:120:829-32.
30. Galandiuk S, Polk HC Jr, Jagelman DG, Fazio VW. Re-emphasis of priorities in surgical antibiotic prophylaxis. Surg Gynecol Obstet 1989:169:219-22.
31. Crossley K, Gardner LC, Task Force on Prophylactic Antibiotics in Surgery. Antimicrobial prophylaxis in surgical patients. JAMA 1981;245:722-6.
32. Currier JS, Campbell H, Platt R, Kaiser AB. Perioperative antimicrobial prophylaxis in middle Tennessee. 1989-1990. Rev Infect Dis 1991;13(suppl 10):S874-78.
33. Shapiro M, Townsend TR, Rosner B, Kass EH. Use of antimicrobial drugs in general hospitals: patterns of prophylaxis. N Engl J Med 1979;301:351-5.
34. Richet HM, Chidiac C. Prat A. et al. Analysis of risk factors for surgical wound infections following vascular surgery. Am J Med 1991;91(suppl 3B): 170S-2S.
35. DiPiro JT, Cheung RPF, Bowden TA Jr. Mansberger JA. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg 1986:152:552-9.
36. DiPiro JT, Cheung RPF, Bowden TA Jr. Mansberger JA. Purpose of quality standards for infectious diseases. Clin Infect Dis 1994:18:421.
37. McGowan JE Jr, C’hesney PJ. Crossley KB, LaForce FM. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. J Infect Dis 1992:165:1-13.
38. Hemsell DL. Prophylactic antibiotics in gynecologic and obstetric surgery. Rev Infect Dis 1991; 13(suppl 10):S821-41.
39. Shapiro M, Schoenbaum SC, Tager IB, Munoz A, Polk BF. Benefit-cost analysis of antimicrobial prophylaxis in abdominal and vaginal hysterectomy. JAMA 1983;249:1290-4.
40. Rayburn W, Varner M, Galask R, Petzold CR, Piehl E. Comparison of moxalactam and cefazolin as prophylactic antibiotics during cesarean section. Antimicrob Agents Chemother 1985:27:337-9.
41. Tuomala RE, Fischer SG, Munoz A, Souney PF, Steele L, Polk BF. A comparative trial of cefazolin and moxalactam as prophylaxis for preventing infection after abdominal hysterectomy, Obstet Gynecol 1985;66:372-6.
42. Morris DL, Wilson SR, Pain J, et al. A comparison of aztreonam metronidazole and cefotaxime/metronidazole in elective colorectal surgery: antimicrobial prophylaxis must include gram-positive cover. J Antimicrob Chemother 1990;25:673-8.
43. Johnson JT, Yu VL. Antibiotic use during major head and neck surgery. Ann Surg 1988;207:108-11.
44. Ariano RE, Zhanel GG. Antimicrobial prophylaxis in coronary bypass surgery: a critical appraisal. D1CP 1991:25:478-84.
45. Shapiro M, Munoz A, Tager IB, Schoenbaum SC. Polk BF. Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. N Engl J Med 1982;307:1961-6.
46. Kaiser AB, Herrington JL Jr, Jacobs JK, Mulherin JL Jr. Roach AC. Sawyers JL. Cefoxitin versus erythromycin, neomycin, and cefazolin in colorectal operations: importance of the duration of the surgical procedures. Ann Surg 1983;198:525-30.
47. Coppa GF, Eng K. Factors involved in antibiotic selection in elective colon and rectal surgery. Surgery 1988:104:853-8.
48. Goldman DA, Hopkins CC, Karchmer AW, et al. Cephalothin prophylaxis in cardiac valve surgery: a prospective, double-blind comparison of two-day and six-day regimens. J Thorac Cardiovasc Surg 1977;73:470-9.
49. Platt R, Munoz A. Stella J, Van Devanter S, Koster JK Jr. Antibiotic prophylaxis for cardiovascular surgery: efficacy with coronary artery bypass. Ann Intern Med 1984:101:770-4.